(Q48562728)

12 February 2018

title

Monoclonal antibodies in the treatment of central nervous system malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591076

12 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591076

12 October 2022

J. T. Kemshead

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591076

12 October 2022

V. Papanastassiou

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591076

12 October 2022

H. B. Coakham

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591076

12 October 2022

B. L. Pizer

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1591076

12 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1591076

12 October 2022

publication date

1 January 1992

1 reference

12 February 2018

European Journal of Cancer

published in

1 reference

12 February 2018

volume

1 reference

12 February 2018

issue

2-3

1 reference

12 February 2018

page(s)

511-513

1 reference

12 February 2018

131-I coupled to monoclonal antibodies as therapeutic agents for neuroectodermally derived tumors: fact or fiction?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

Quantitative distribution of 131I-labelled monoclonal antibodies administered by the intra-ventricular route

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

The role of chemotherapy in the treatment of gliomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980090-5

7 January 2021

10.1016/S0959-8049(05)80090-5

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018